Stay updated on Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial

Sign up to get notified when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page has been updated to include new contact information for the Principal Investigator, Adam J. Esbenshade, and the latest revision version. Additionally, previous dates and a suspended status have been removed.
    Difference
    0.3%
    Check dated 2025-05-04T04:12:44.000Z thumbnail image
  2. Check
    19 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect new information regarding a clinical trial for recurrent low-grade glioma, including changes in principal investigators, contact details, and the number of study locations. Additionally, the trial's start date has been updated to April 17, 2025.
    Difference
    36%
    Check dated 2025-04-19T23:28:44.000Z thumbnail image
  3. Check
    26 days ago
    Change Detected
    Summary
    The web page has updated its date information, adding new dates for April 8 and April 9, 2025, while removing the previous dates of April 2 and April 3, 2025.
    Difference
    0.1%
    Check dated 2025-04-12T17:29:15.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page has updated its contact information for the Principal Investigator, Monia Marzouki, and the site public contact, while also reflecting a new revision number and last update date.
    Difference
    0.5%
    Check dated 2025-04-05T12:44:03.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page has undergone significant changes in its principal investigators and contact information, with Laura K. Metrock and Scott M. Bradfield now listed as principal investigators, while Andrea R. Whitfield, Monia Marzouki, and their associated contact details have been removed.
    Difference
    0.8%
    Check dated 2025-03-28T21:10:09.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of key contact information for principal investigators and the addition of new dates, indicating a potential shift in project timelines or personnel.
    Difference
    0.6%
    Check dated 2025-03-21T10:28:17.000Z thumbnail image

Stay in the know with updates to Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.